BioCryst Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (BCRX)

Q1 2010 Earnings Call

April 28, 2010 11:00 am ET

Executives

Robert Bennett - IR

Jon Stonehouse - CEO

Bill Sheridan - CMO

Stuart Grant - CFO

Analysts

Charles Duncan - JMP Securities

Bret Holley - Oppenheimer

Steve Byrne - Merrill Lynch

Bill Pottery - DFL

Steven Harr - Morgan Stanley

Ren Benjamin - Rodman

Joseph Schwartz - Leerink Swann

Michael Murphy - New World Investor

Presentation

Operator

» BioCryst Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
» BioCryst Pharmaceuticals, Inc. Q4 2007 Earnings Call Transcript
» Spectranetics Corp. Q1 2010 Earnings Call Transcript

Welcome to today's BioCryst first quarter 2010 conference call. Today's call is being recorded. At this time for opening remarks and introduction, I'll turn the call over to Mr. Robert Bennett. Please go ahead, sir.

Robert Bennett

Thank you and good morning. Welcome to BioCryst first quarter 2010 financial results conference call and corporate update. Today's press release are available on our website at biocryst.com. At this time, all participants are in a listen-only mode. Later we will open up the call for questions. Instructions for Q&A will be provided at that time.

Joining me today on the call are Jon Stonehouse, our Chief Executive Officer; Bill Sheridan, our Chief Medical Officer; and Stuart Grant, Chief Financial Officer.

Before we begin, I'll read a formal statement regarding risk factors associated with today's call. Today's conference call will contain forward-looking statements, including statements regarding future results, unaudited and forward-looking financial information and the company's performance or achievements. These statements are subject to known and unknown risks and uncertainties, which may cause our actual results, performance or achievements to be materially different from any future results or performance expressed or implied in this presentation.

You should not place undue reliance on the forward-looking statements. For additional information, including important risk factors, please refer to BioCryst's documents filed with the SEC, which can be found on our company website.